Key facts
- It has raised $14.4M; the latest was Later Stage VC in Sep 2025.
- Notable investors include Addor Capital, Fortune Capital, CMG SDIC Fund, CDIB Capital Group.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for VDK NaturaSyn
- ·The full record, as it builds
Funding rounds
No funding rounds for VDK NaturaSyn are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VDK NaturaSyn
Manufacturer of synthetic natural compound chemical ingredients intended for food, dietary supplements and active pharmaceutical ingredients. The company specailises in microbial fermentation-based APIs, bioactive food additives, nutritional supplement ingredients and scalable synthetic biology platforms, thereby supporting environmentally friendly production and meeting diverse health and wellness needs.
- Sector
- Materials and Resources
- HQ
- Baoding, China
- Founded
- 2013
- Employees
- 330
- Website
- vdk.com/
- Ownership
- Privately Held (backing)
VDK NaturaSyn doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VDK NaturaSyn shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VDK NaturaSyn in its N-PORT filings yet. We sweep new filings monthly.